Remove Branding Remove Packaging Remove Production
article thumbnail

Top 10 Most Innovative Food Companies of 2025, According to Fast Company

XTalks

Fast Company also flagged four foodtech trends to likely define 2025: personalized nutrition powered by data, AIenabled product development, alternativeprotein scaleup and robotics in processing. While in Europe, TraceOne and Citeo launched an automated recyclabilityscoring integration for packaging with seven French brands in pilot.

article thumbnail

Key Considerations for Generic Drug Stability Testing

Drug Patent Watch

Behind the scenes, generic drug manufacturers are working tirelessly to ensure that their products are safe, effective, and identical to their branded counterparts. It helps them to identify potential issues early on, make adjustments as needed, and ultimately bring a high-quality product to market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study Reveals That 20% of Food and Beverage Products in the US Contain Synthetic Dyes

Scienmag

As the quest for healthier eating continues to gain momentum, a new study sheds light on a concerning reality in the American food landscape—19% of packaged foods and beverages are tainted with synthetic food dyes. These include confectionery items, sugar-sweetened beverages, ready-to-eat meals, breakfast cereals, and popular baked goods.

article thumbnail

Would the Industry Survive 200% Pharma Tariffs?

Pharma Marketing Network

If 200% tariffs were placed on imported drugs or pharmaceutical ingredients, costs would surge not only for foreign-made medications but also for branded drugs manufactured in the U.S. Even American-made branded drugs rely heavily on foreign-sourced components. that depend on global supply chains. Currently, the U.S. The consequences?

article thumbnail

The Role of Quality Assurance in Generic Drugs

Drug Patent Watch

These dedicated individuals play a critical role in ensuring that generic drugs meet the same high standards as their brand-name counterparts. From inspecting manufacturing facilities to testing finished products, QA teams work tirelessly to guarantee that every pill, tablet, or capsule that reaches the market is safe and effective.

article thumbnail

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

Factors assessed include the ratio of approved medicines to those that are reimbursed, volume of products reimbursed per year, and time to pricing and reimbursement. On average, 58% of branded drugs approved between 2021 and 2024 in Europe have either fully or restricted reimbursement.

article thumbnail

The rise of GLP-1 drugs: Transforming weight loss treatment

Bio Pharma Dive

The black and gray market risks Ben warned about the proliferation of counterfeit GLP-1 drugs in unregulated markets, posing significant dangers to patients who might unknowingly use ineffective or harmful products.